Subscribe to RSS - Criticism

The media's role in distorting science

iPhone

Did you read about the survey that said 82 percent of adults had "sexted" sometime in the past year? So did Robert Gebelhoff, who writes about the flimsy science behind that attention-grabbing statistic: "Examples like this are legion in the world of science journalism. As a result, the scientific community has lately been making an effort try to end the stream of misleading articles — going so far as to redesign the way academic journals review and publish studies."

An experts' beef about quote selection

Quotation marks

Forensic linguist Claire Hardaker tried her best to beg off responding to an insistent reporter's questions about the demographics of Internet trolls, but she finally gave in, sending a nuanced reply via email. "So what made it into the Telegraph, with its headline 'Why are most internet trolls men?' three whole weeks later?" she wrote. A four-word quote from her saying that there is “lots of anecdotal evidence” that most trolls are male. "Yeah," Hardaker concludes.

Web metrics and journalism's decline

Coffee cup

Jeff Wise interviews Gary Schwitzer of HealthNewsReview.org about the sorry state of health reporting in the media today, compared with years gone by: "Click rates just dominate. It is really sad to talk with 30-, 40-year veterans who know their stuff, and they know what they’re being judged on. It’s not the quality or the shoe leather or the extra source or the angle that nobody else has. It’s only the web metrics, on many days. I don’t know, maybe I should retire."

A questionable story on prostate cancer

Prostate cancer cells

Denise Grady writes about the promotion of a study on advanced prostate cancer with alarming results that earned it media coverage but which were quickly challenged by the American Cancer Society for unsound statistical methods: "The frightening news appears to be a false alarm — the product of a study questioned by other researchers but promoted with an incendiary news release and initially reported by some news media with little or no analysis from outside experts."

Good and bad in new stent coverage

Stent

Health News Review examines stories from the Associated Press and Reuters on a new stent for treating coronary artery disease. The reviewers praise the AP version but not the Reuters story: "Its almost giddy approach to the FDA announcement belies the fact that long-term safety and efficacy data are not yet in hand. Put another way, no one yet knows if these dissolvable stents will make a practical difference in heart disease patient outcomes."

Too much skepticism on cell phones?

Woman holding cell phone

Few news outlets gave serious coverage to the latest findings on cell phones and cancer, and that could be a mistake, Paul Raeburn writes: "It’s not enough to put coverage on autopilot and default into doubt. The journalistic wisdom of today seems to suggest that reporters should understate potential risks — and indeed, it’s important to avoid fear-mongering and hype. But it’s also important to remain open to new research and the potential concerns it may raise."

On the New Yorker's epigenetics story

Double helix illustration

Pulitzer-prize winning physician/author Siddhartha Mukherjee has a new book on epigenetics, and last week the New Yorker published an excerpt, whereupon scientists in the field hit the roof, Aleszu Bajak writes: "Epigenetics is complex stuff, and Mukherjee simplified it to the point of error. Of course, that’s a hazard for any science storyteller." More from Brian Resnick and from Jerry Coyne here, here, and here.

Peer review for climate change news

Norwegian glacier

Daniel Nethery and Emmanuel Vincent write about their plans for Climate Feedback, where climate scientists review news stories: "Our collective reviews allow scientists from all over the world to provide feedback in a timely, effective manner. We then publish an accessible synthesis of their responses, and provide feedback to editors so that they can improve the accuracy of their reporting." More from Xian Chiang-Waren.

Why the press is to blame for Theranos

Theranos founder Elizabeth Holmes

There are many players in the rapid rise and spectacular fall of the blood-testing startup Theranos, but Nick Bilton points his finger at the news media: "There were no tough questions about whether Theranos’s technology actually worked; just praise. When it seemed that the tech press had vetted [founder Elizabeth] Holmes, she subsequently went mainstream. She got her New Yorker profile, and her face appeared on the cover of T: The New York Times Style Magazine, among others."

About those killer vegetables

Field of vegetables, image via Shutterstock

How did a paper on some long-term changes in human genetics produce headlines saying that being a vegetarian can kill you? Andrew Porterfield examines coverage of the Cornell University study: "It’s too tempting for many outlets to talk about oversimplified solutions to things like obesity, heart disease, or cancer. It’s equally easy, as in the Cornell FADS allele story, to quickly mold hypothesis into proven outcome." More from Kaleigh Rogers.